Bausch Health Companies BHC Salix — Operating Income (Loss)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bausch Health Companies's salix — operating income (loss).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bausch Health Companies's salix — operating income (loss)?
- Bausch Health Companies (BHC) reported salix — operating income (loss) of $468M in Q1 2026.
- How has Bausch Health Companies's salix — operating income (loss) changed year-over-year?
- Bausch Health Companies's salix — operating income (loss) increased by 26.1% year-over-year, from $371M to $468M.
- What is the long-term trend for Bausch Health Companies's salix — operating income (loss)?
- Over 4 years (2021 to 2025), Bausch Health Companies's salix — operating income (loss) has grown at a 6.6% compound annual growth rate (CAGR), from $1.49B to $1.93B.
- What does salix — operating income (loss) mean?
- Measures the profitability of the Salix segment by subtracting operating expenses, including R&D and SG&A, from total segment revenues. This metric evaluates the core operational performance and margin profile of the segment independent of corporate-level financing or tax structures. It is a key indicator of the segment's ability to generate sustainable cash flow from its operations.